Comparative Evaluation of salivary LDH and CRP in patients

Phase 2

Recruiting

• Conditions: Erosive lichen planus.; Other lichen planus; L43.8

• Registration Number: IRCT20160126026209N2
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 27 June 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Suffering from oral erosive lichenoid reaction that has been definitely diagnosed by histopathologic diagnosis
The patient has consent to participate in the study

Exclusion Criteria

Presence of systemic and inflammatory disease (e.g. Covid disease, blood system malignancies, etc.) that affects study factors (LDH, CRP)
The patient had been receiving former treatment for the study lesion
Presence of another lesion in the patient's mouth

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The measure of salivary lactate dehydrogenase. Timepoint: measurement of lactate dehydrogenase just before the beginning of systemic treatment and 14 and 28 days after beginning the use of systemic corticosteroid. Method of measurement: Non-stimulating saliva sampling.;The measure of salivary C Reactive Protein. Timepoint: measurement of C Reactive Protein just before the beginning of systemic treatment and 14 and 28 days after beginning the use of systemic corticosteroid. Method of measurement: Non-stimulating saliva sampling.